RK

Rajesh Kumar

Active Director Director DIN 02673221
DIN 02673221 First appointment Sep 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2009
Shareholding value Locked Premium profile

About Rajesh Kumar

Data last updated:

Rajesh Kumar has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Kenosis Biotech India Limited. Engaged in Technology. Contributes to corporate operations.

DIN 02673221
Primary Designation Director
First Appointment 10 Sep 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Kenosis Biotech India Limited U51397GJ2009PLC058079
Director10 Sep 20092009Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kenosis Biotech India Limited
Premium access

Shareholding and investment profile for Rajesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar

Rajesh Kumar has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Kenosis Biotech India Limited. Engaged in Technology. Contributes to corporate operations.

Rajesh Kumar is associated with 1 company as Director.

Rajesh Kumar has expertise in Technology.

Rajesh Kumar has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available